Beijing Balance Medical TechnologyLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Lei Jin
Chief executive officer
CN¥720.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 67.3% |
| Management average tenure | no data |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Beijing Balance Medical TechnologyLtd (SHSE:688198) Will Be Hoping To Turn Its Returns On Capital Around
Dec 20
Beijing Balance Medical Technology Co.,Ltd.'s (SHSE:688198) 42% Jump Shows Its Popularity With Investors
Oct 09Beijing Balance Medical TechnologyLtd (SHSE:688198) Strong Profits May Be Masking Some Underlying Issues
Aug 28Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) Not Flying Under The Radar
Jul 03If EPS Growth Is Important To You, Beijing Balance Medical TechnologyLtd (SHSE:688198) Presents An Opportunity
Jun 04The Consensus EPS Estimates For Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) Just Fell A Lot
May 10The Returns On Capital At Beijing Balance Medical TechnologyLtd (SHSE:688198) Don't Inspire Confidence
Apr 11CEO
Lei Jin (70 yo)
no data
Tenure
CN¥720,000
Compensation
Dr. Lei Jin serves as Chairman of the Board and General Manager at Beijing Balance Medical Technology Co.,Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & GM | no data | CN¥720.00k | 67.31% CN¥ 9.9b | |
| Financial Director & Director | 2.3yrs | CN¥600.00k | 0.0031% CN¥ 449.9k | |
| Deputy GM & Director | no data | CN¥612.00k | no data | |
| Deputy GM & Director | 4yrs | CN¥599.00k | no data | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Director | no data | CN¥413.40k | no data | |
| Supervisor | 6.1yrs | no data | no data | |
| Supervisor | no data | no data | no data | |
| Director | 2.7yrs | CN¥180.40k | no data | |
| Independent Director | no data | no data | 0.017% CN¥ 2.5m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
2.5yrs
Average Tenure
45yo
Average Age
Experienced Board: 688198's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 17:33 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Balance Medical Technology Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Yiling Chen | Guosen Securities Co., Ltd. |
| Hanqing Zhu | Guosen Securities Co., Ltd. |